NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cancer Research UK

Cancer Research UK

Overview

Cancer Research UK is a non-profit organization that acts as a major investor in cancer research, providing early-stage capital and venture creation support to oncology ventures through its innovation arm, Cancer Research Horizons.

Year Founded

2002

Portfolio Companies

9

Investments

Cancer Research UK investments
CompanyDateStageLead
Myricx BioJul 2024Series A-
Yemaachi BiotechnologyMar 2024GrantCo-investor
Coherence NeuroAug 2022GrantCo-investor
Boundless BioJun 2022GrantCo-investor
MultiplAI HealthNov 2021AcceleratorCo-investor

Key People

Beth Sitek

Co-Founder of The Sunflower Foundation

Carmela R.

Content Strategy Partner

Simon Boulton

Director, Cancer Research UK, RadNet - City of London

Amar S Ahmad

Principal Statistician

Andrew Rowan

Principal Scientific Officer

Jade Lyons Rimmer

Principal Medical Writer

Susan Minogue

Principal Clinical Data Manager

Chris Goddings

Senior Portfolio Manager

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon
Year Founded2002

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.